Weight-loss drug orlistat may damage the liver

Recently, the U.S. Food and Drug Administration (FDA) announces that: is for weight-loss drug orlistat may cause harm to the liver for investigation. Prescription drugs for the drug Xenical, the non-prescription drugs as Alli.

FDA’s announcement that from 1999 to 2008, they received a total of 32 cases of patients taking orlistat appeared the report of liver injury, of which 27 cases were hospitalized and 6 patients had signs of liver failure.

Recently, FDA is being Orlistat providers suspected cases of liver injury assessed in order to obtain further data.

However, FDA said that so far, yet there is no definitive evidence that taking the drug is directly linked with liver damage. Consumers can continue to follow the prescription of taking Xenical and under the guidance of doctors to continue to take non-prescription drug Alli. FDA will soon release on the re-evaluation of orlistat results, if the use of orlistat in the event of the consumer, such as yellowing of the skin, jaundice, weakness and stomach pain symptoms, you should consult a timely manner to healthcare professionals.

Tags: ,

Comments are closed.